Basilea Pharmaceutica AG (SWX:BSLN)
43.60
-0.70 (-1.58%)
May 13, 2025, 5:31 PM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 164 employees as of December 31, 2024. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
1.27M CHF
Profits / Employee
473.13K CHF
Market Cap
537.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,249 |
Novartis AG | 75,883 |
Lonza Group AG | 18,944 |
Alcon | 25,599 |
Galderma Group AG | 6,545 |
Straumann Holding AG | 11,815 |
Sandoz Group AG | 22,049 |
Sonova Holding AG | 18,151 |
Basilea Pharmaceutica AG News
- 5 days ago - Assessment of the 14-Alpha Demethylase Inhibitors Pipeline Landscape 2025, Featuring Insights Into Oteseconazole (Mycovia Pharmaceuticals) and Isavuconazonium (Basilea Pharmaceutica) - GlobeNewsWire
- 19 days ago - Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea - GlobeNewsWire
- 2 months ago - Basilea Pharmaceutica Ltd (XSWX:BSLN) Full Year 2024 Earnings Call Highlights: A Year of Robust ... - GuruFocus
- 2 months ago - Full Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 2 months ago - Basilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of Zevtera - Seeking Alpha
- 2 months ago - Basilea Pharmaceutica AG (BPMUF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Basilea Pharmaceutica AG 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook - Seeking Alpha